GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Thursday, 28 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 86 or. 6 percent, to $138.69. Biogen Idec fell $2.12 or. 6 percent, to $341.24. Celgene Corp. fell$. 04 or percent, to $94.70.

  • Midday Glance: Biotechnology companies Thursday, 28 Aug 2014 | 1:19 PM ET

    Amgen Inc. rose $1.07 or. 8 percent, to $138.90. Biogen Idec fell $1.58 or. 5 percent, to $341.78. Celgene Corp. rose$. 01 or percent, to $94.75.

  • Final Glance: Biotechnology companies Wednesday, 27 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 56 or. 4 percent, to $137.83. Biogen Idec rose$. 37 or. 1 percent, to $343.36. Celgene Corp. fell$. 92 or 1.0 percent, to $94.74.

  • Most active Nasdaq-traded stocks Wednesday, 27 Aug 2014 | 6:02 PM ET

    Achillion Pharmaceuticals Inc. fell 2.6 percent to $11.45 with 13,290,700 shares traded. Apple Inc. rose 1.2 percent to $102.13 with 46,357,900 shares traded. Cisco Systems Inc. was unchanged at $24.80 with 15,324,700 shares traded.

  • Aug 27- Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

  • Early Glance: Biotechnology companies Wednesday, 27 Aug 2014 | 10:17 AM ET

    Amgen Inc. rose$. 09 or. 1 percent, to $137.36. Biogen Idec fell $3.75 or 1.1 percent, to $339.24. Celgene Corp. fell$. 64 or. 7 percent, to $95.02.

  • Final Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 6:05 PM ET

    Amgen Inc. rose $2.48 or 1.8 percent, to $137.27. Biogen Idec rose$. 29 or. 1 percent, to $342.99. Celgene Corp. rose $2.26 or 2.4 percent, to $95.66.

  • Midday Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 1:31 PM ET

    Amgen Inc. rose $2.37 or 1.8 percent, to $137.16. Biogen Idec fell $1.54 or. 4 percent, to $341.16. Celgene Corp. rose $2.04 or 2.2 percent, to $95.44.

  • Most active Nasdaq-traded stocks Tuesday, 26 Aug 2014 | 1:31 PM ET

    Achillion Pharmaceuticals Inc. rose 9.0 percent to $11.75 with 18,098,400 shares traded. Apple Inc. fell. 6 percent to $100.89 with 32,310,800 shares traded. Cisco Systems Inc. rose. 4 percent to $24.81 with 16,479,500 shares traded.

  • Early Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 11:11 AM ET

    Amgen Inc. rose$. 91 or. 7 percent, to $135.70. Biogen Idec fell $1.34 or. 4 percent, to $341.36. Celgene Corp. rose $1.02 or 1.1 percent, to $94.42.

  • *Best Buy tumbles after results, DSW higher. *Digital Ally gains before bell, has tripled this month. Nonetheless, further gains may be a challenge without positive catalysts and amid potential headwinds such as a reduction in Federal Reserve stimulus and a simmering conflict between Ukraine and Russia.

  • *Digital Ally gains before bell, has tripled this month. NEW YORK, Aug 26- U.S. stock index futures were little changed on Tuesday, with investors finding few reasons to buy after a rally in the previous session that took the S&P 500 above 2,000 for the first time.

  • Most active Nasdaq-traded stocks Monday, 25 Aug 2014 | 6:24 PM ET

    Achillion Pharmaceuticals Inc. rose 10.5 percent to $10.78 with 14,301,300 shares traded. Apple Inc. rose. 2 percent to $101.54 with 39,098,300 shares traded. Cisco Systems Inc. rose. 2 percent to $24.70 with 18,918,400 shares traded.

  • Final Glance: Biotechnology companies Monday, 25 Aug 2014 | 6:24 PM ET

    Amgen Inc. rose $1.97 or 1.5 percent, to $134.79. Biogen Idec rose $2.73 or. 8 percent, to $342.70. Celgene Corp. rose $1.78 or 1.9 percent, to $93.40.

  • Biotechs rallied after Roche Holding AG agreed to buy InterMune Inc for $8.3 billion in cash, the latest vote of confidence in a sector that many, including Federal Reserve Chair Janet Yellen, are worried is overvalued. InterMune jumped 36 percent to $73.00, with the Nasdaq Biotech index up 2.4 percent.

  • Early Glance: Biotechnology companies Monday, 25 Aug 2014 | 10:37 AM ET

    Amgen Inc. rose $1.75 or 1.3 percent, to $134.57. Biogen Idec rose $4.39 or 1.3 percent, to $344.36. Celgene Corp. rose $1.61 or 1.8 percent, to $93.23.

  • Final Glance: Biotechnology companies Friday, 22 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 29 or. 2 percent, to $132.82. Biogen Idec rose $1.32 or. 4 percent, to $339.97. Celgene Corp. fell$. 04 or percent, to $91.62.

  • Most active Nasdaq-traded stocks Friday, 22 Aug 2014 | 1:22 PM ET

    Apple Inc. rose. 7 percent to $101.32 with 43,141,300 shares traded. Cisco Systems Inc. fell 1.0 percent to $24.65 with 22,216,700 shares traded. Facebook Inc. was unchanged at $74.57 with 20,568,200 shares traded.

  • Midday Glance: Biotechnology companies Friday, 22 Aug 2014 | 1:21 PM ET

    Amgen Inc. rose$. 73 or. 6 percent, to $133.26. Biogen Idec rose $2.22 or. 7 percent, to $340.87. Celgene Corp. rose$. 09 or. 1 percent, to $91.75.

  • Final Glance: Biotechnology companies Thursday, 21 Aug 2014 | 6:08 PM ET

    Amgen Inc. fell$. 15 or. 1 percent, to $132.53. Biogen Idec fell $3.93 or 1.1 percent, to $338.65. Celgene Corp. fell$. 34 or. 4 percent, to $91.66.